Trial Links Potential Biomarkers To Drugs For Lung Cancer, To Help Target Therapies
NCCTG Plans To Conduct Phase II Study Of Brostallicin Plus Cisplatin For mTNBC
Long-Term Results Of STAR Find Raloxifene Causes Fewer, Less Severe Side Effects
Controlling Diabetes May Cut Liver Cancer Risk, Study Finds
Colorectal Cancer Screening Practices Need Improvement, CDC Practice Study Finds
Healthcare Utilization Figures More Than Biology In Disparity
Phase III Lung and Pancreatic Cancer Trials Are Stopped
NCI Cooperative Group Clinical Trials Approved
Trending Stories
- In the Headlines: What’s in Trump’s draft budget?
- Trump administration seeks to slash NIH by roughly 40% as 27 institutes and centers are whittled down to eight
NCI to remain intact, but its finances are uncertain; FDA is spared big cuts - John Burklow replaced by Seana Cranston as NIH chief of staff
- DOD cancer research programs face 57% funding cut in year-long continuing resolution
Pancreatic, lung, kidney cancer research programs eliminated - In her own words: Rathmell reflects on her priorities and values—and encourages everyone to do the same
- NCI summarizes changes to the CCSG NOFO